Randy H. Thurman - Sep 29, 2022 Form 4 Insider Report for TFF Pharmaceuticals, Inc. (TFFP)

Role
Director
Signature
/s/ Randy Thurman, by Kirk Allen Coleman, as Attorney-in-Fact
Stock symbol
TFFP
Transactions as of
Sep 29, 2022
Transactions value $
-$72,056
Form type
4
Date filed
9/30/2022, 05:20 PM
Previous filing
Mar 24, 2022
Next filing
Mar 31, 2023

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TFFP Stock Options (Right to Buy) Options Exercise $0 -40.3K -32.22% $0.00 84.7K Sep 29, 2022 Common Stock 40.3K $2.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold in the open market in multiple transactions at prices ranging from $4.18 to $4.57. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to TFF Pharmaceuticals, Inc., any stockholder of TFF Pharmaceuticals, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
F2 The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.